{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-074258","form_type":"8-K","ticker":"ALXO","cik":"0001810182","company_name":"ALX ONCOLOGY HOLDINGS INC","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.252458+00:00","generated_at":"2026-06-01T04:09:17.033512+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"ALX Oncology annual meeting results: all three director nominees elected, proposals approved","bullets":["Corey Goodman, Jason Lettmann, Sophia Randolph elected as Class I directors for terms until 2027.","Advisory vote on executive compensation approved: 40,935,354 for, 1,422,239 against, 34,391 abstain.","Ratification of KPMG as independent auditor for FY 2024 approved: 47,698,670 for, 11,338 against, 2,733 abstain.","Broker non-votes: 5,320,757 on director elections and advisory compensation vote."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-074258","json":"https://secwatch.observer/filing/0000950170-24-074258.json","markdown":"https://secwatch.observer/filing/0000950170-24-074258.md","text":"https://secwatch.observer/filing/0000950170-24-074258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810182/000095017024074258/0000950170-24-074258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810182/000095017024074258/alxo-20240612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:09:17.033512+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}